1. Home
  2. FOLD vs PATK Comparison

FOLD vs PATK Comparison

Compare FOLD & PATK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FOLD
  • PATK
  • Stock Information
  • Founded
  • FOLD 2002
  • PATK 1959
  • Country
  • FOLD United States
  • PATK United States
  • Employees
  • FOLD N/A
  • PATK N/A
  • Industry
  • FOLD Biotechnology: Pharmaceutical Preparations
  • PATK Auto Parts:O.E.M.
  • Sector
  • FOLD Health Care
  • PATK Consumer Discretionary
  • Exchange
  • FOLD Nasdaq
  • PATK Nasdaq
  • Market Cap
  • FOLD 2.9B
  • PATK 2.7B
  • IPO Year
  • FOLD 2007
  • PATK N/A
  • Fundamental
  • Price
  • FOLD $6.16
  • PATK $82.61
  • Analyst Decision
  • FOLD Buy
  • PATK Buy
  • Analyst Count
  • FOLD 10
  • PATK 10
  • Target Price
  • FOLD $16.22
  • PATK $101.53
  • AVG Volume (30 Days)
  • FOLD 5.0M
  • PATK 253.7K
  • Earning Date
  • FOLD 05-01-2025
  • PATK 05-01-2025
  • Dividend Yield
  • FOLD N/A
  • PATK 2.37%
  • EPS Growth
  • FOLD N/A
  • PATK N/A
  • EPS
  • FOLD N/A
  • PATK 4.16
  • Revenue
  • FOLD $543,141,000.00
  • PATK $3,785,611,000.00
  • Revenue This Year
  • FOLD $19.85
  • PATK $3.48
  • Revenue Next Year
  • FOLD $23.50
  • PATK $5.93
  • P/E Ratio
  • FOLD N/A
  • PATK $20.63
  • Revenue Growth
  • FOLD 28.25
  • PATK 8.12
  • 52 Week Low
  • FOLD $5.81
  • PATK $67.72
  • 52 Week High
  • FOLD $12.65
  • PATK $98.90
  • Technical
  • Relative Strength Index (RSI)
  • FOLD 41.91
  • PATK 43.93
  • Support Level
  • FOLD $6.03
  • PATK $83.23
  • Resistance Level
  • FOLD $6.37
  • PATK $89.44
  • Average True Range (ATR)
  • FOLD 0.24
  • PATK 2.38
  • MACD
  • FOLD 0.04
  • PATK -0.42
  • Stochastic Oscillator
  • FOLD 41.67
  • PATK 4.79

About FOLD Amicus Therapeutics Inc.

Amicus Therapeutics Inc is a biotechnology company focused on discovering, developing and delivering medicines for people living with rare metabolic diseases. The company is engaged in developing a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of advanced therapies to treat a range of devastating rare and orphan diseases.

About PATK Patrick Industries Inc.

Patrick Industries Inc makes and sells building products and materials for recreational vehicles and manufactured housing. The company is organized into two segments based on product type: manufacturing and distribution. The manufacturing segment, which generates the majority of revenue, sells laminated and vinyl products that include furniture, shelving, cabinets, bath fixtures, and countertops. The distribution segment sells prefinished wall and ceiling panels, as well as electrical and plumbing products for the RV and manufactured housing industries. One of the firm's RV customers makes up a portion of revenue.

Share on Social Networks: